- Home
- PROK vs AAOI Comparison
PROK vs AAOI Comparison
Compare PROK & AAOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- AAOI
- Stock Information
- Founded
- PROK 2015
- AAOI 1997
- Country
- PROK United States
- AAOI United States
- Employees
- PROK N/A
- AAOI N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- AAOI Semiconductors
- Sector
- PROK Health Care
- AAOI Technology
- Exchange
- PROK Nasdaq
- AAOI Nasdaq
- Market Cap
- PROK 271.2M
- AAOI 561.7M
- IPO Year
- PROK N/A
- AAOI 2013
- Fundamental
- Price
- PROK $1.98
- AAOI $19.00
- Analyst Decision
- PROK Buy
- AAOI Buy
- Analyst Count
- PROK 5
- AAOI 3
- Target Price
- PROK $4.50
- AAOI $15.33
- AVG Volume (30 Days)
- PROK 999.3K
- AAOI 2.6M
- Earning Date
- PROK 11-12-2024
- AAOI 11-07-2024
- Dividend Yield
- PROK N/A
- AAOI N/A
- EPS Growth
- PROK N/A
- AAOI N/A
- EPS
- PROK N/A
- AAOI N/A
- Revenue
- PROK N/A
- AAOI $206,944,000.00
- Revenue This Year
- PROK N/A
- AAOI $14.87
- Revenue Next Year
- PROK N/A
- AAOI $78.81
- P/E Ratio
- PROK N/A
- AAOI N/A
- Revenue Growth
- PROK N/A
- AAOI N/A
- 52 Week Low
- PROK $1.12
- AAOI $6.66
- 52 Week High
- PROK $4.44
- AAOI $24.75
- Technical
- Relative Strength Index (RSI)
- PROK 51.48
- AAOI 68.92
- Support Level
- PROK $1.67
- AAOI $16.93
- Resistance Level
- PROK $1.90
- AAOI $19.46
- Average True Range (ATR)
- PROK 0.17
- AAOI 1.37
- MACD
- PROK 0.04
- AAOI 0.27
- Stochastic Oscillator
- PROK 90.91
- AAOI 92.42
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About AAOI Applied Optoelectronics Inc.
Applied Optoelectronics Inc is a provider of fiber-optic networking products for the Internet data center, cable television, telecommunications and fiber-to-the-home end markets. The company focuses on designing and manufacturing a range of optical communication products from components, to subassemblies, and modules to complete turn-key equipment. Demand for Applied Optoelectronics is driven by bandwidth demand in end markets. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The company derives maximum revenue from Taiwan.